To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.

Fact Sheet API

Bill Number

HR 2064

Introduced

Apr 3, 2019

Latest Action

Subcommittee Hearings Held.

Sponsor

Cosponsors

Topics

Consumer affairs Government information and archives Health Health technology, devices, supplies Inflation and prices Prescription drugs

Full Text

View Full Bill Text

Votes

Summary

This bill requires drug manufacturers to provide the Department of Health and Human Services with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.

Actions

May 21, 2019

Subcommittee Hearings Held.
Apr 4, 2019

Referred to the Subcommittee on Health.
Apr 3, 2019

Referred to the Subcommittee on Health.
Apr 3, 2019

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 3, 2019

Introduced in House

Amendments

Related Bills